Health Products

Auro Pharma Losartan product recall (2021-10-12)

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type I

Summary

Product

A. Auro-Losartan HCT 50mg/12.5mg

Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberCompaniesBrand nameDIN, NPN, DIN-HIMDosage formStrength
ACO1021003A, QY1018012-B, QY1018013-A, QY1018014-A, QY1018015-A, QY1019009-D, QY1018010-A, QY1018011-A, QY1018012-A, QY1019009-A
Recalling Firm
Auro Pharma Inc.
3700 Steeles Ave. W
Woodbridge
L4L 8K8
Ontario
CANADA
Marketing Authorization Holder
Auro Pharma Inc.
3700 Steeles Ave. W
Woodbridge
L4L 8K8
Ontario
CANADA
Auro-Losartan HCT 100mg/12.5mgDIN 02423650Tablet Losartan Potassium 100mg                                Hydrochlorothiazide 12.5mg
ACI1021007A, QX1019011-A, QX1019010-B, QX1019008-A, QX1019009-B, QX1019007-A
Recalling Firm
Auro Pharma Inc.
3700 Steeles Ave. W
Woodbridge
L4L 8K8
Ontario
CANADA
Marketing Authorization Holder
Auro Pharma Inc.
3700 Steeles Ave. W
Woodbridge
L4L 8K8
Ontario
CANADA
Auro-Losartan HCT 100mg/25mgDIN 02423669Tablet Losartan Potassium 100mg                                Hydrochlorothiazide 25mg
ACI5021007E, QX5019009-C, QX5019010-A, QX5019011-E, QX5019009-B
Recalling Firm
Auro Pharma Inc.
3700 Steeles Ave. W
Woodbridge
L4L 8K8
Ontario
CANADA
Marketing Authorization Holder
Auro Pharma Inc.
3700 Steeles Ave. W
Woodbridge
L4L 8K8
Ontario
CANADA
Auro-Losartan HCT 50mg/12.5mgDIN 02423642Tablet Losartan Potassium 50mg                                Hydrochlorothiazide 12.5mg

Introduction

A. Auro-Losartan HCT 50mg/12.5mg

B. Auro-Losartan HCT 100mg/12.5mg

C. Auro-Losartan HCT 100mg/25mg

Reason

Presence of impurity (5-(4 '- ((5 - (Azidomethyl) -2-butyl-4-chloro-1H-imidazol-1-yl) methyl)-[1,1' - biphenyl] - 2-yl) - 1H-tetrazole above the acceptable concentration limit in affected lots.

Depth of distribution

Wholesalers, Retailers, Healthcare Establishments

For more information

Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime